Healthcare artificial intelligence pilots frequently stall when transitioning to production because clean static test datasets fail to account for live electronic health records and regulatory compliance requirements.

Overview Debates Related claims Topics Sources

Inquiry chair Kate Lampard is considering issuing interim regulations and recommendations regarding Oxevision camera technology to prevent further avoidable patient deaths.

In 2021, NHS England raised serious patient safety concerns regarding Oxevision's usage and capability claims with the Medicines and Healthcare products Regulatory Agency.

The Medicines and Healthcare products Regulatory Agency requested clinical evidence from manufacturer Lio Health supporting claims that Oxevision reduced self-harm, but Lio Health failed to provide it.

False pulse readings produced by the Oxevision patient monitoring system were reported to the British Standards Institution in 2023.

India's Ministry of Health launched the Strategy for Artificial Intelligence in Healthcare for India in February 2026 to govern data, validation, deployment, and monitoring.

India's Central Drugs Standard Control Organisation requires artificial intelligence developers to demonstrate clinical validity, demographic diversity in training datasets, version control, and post-market surveillance plans.

A report by the European Academies Science Advisory Council and the Federation of European Academies of Medicine recommended that high-risk artificial intelligence systems in healthcare remain under strict human supervision.

India's Central Drugs Standard Control Organisation issued guidance in July 2026 establishing approval pathways for Software in a Medical Device and Software as a Medical Device.

Regulatory sandboxes allow health authorities to evaluate rapidly evolving artificial intelligence technologies and balance patient safety against clinical innovation.

A joint report by European science academies proposed regulatory sandboxes as controlled, time-limited environments to test medical artificial intelligence tools under regulatory oversight before clinical deployment.

The World Health Organization Regional Office for Africa used artificial intelligence analysis in the Democratic Republic of Congo to reduce situation report generation time from a full working day to one hour.

Response teams in the Democratic Republic of Congo fighting the Bundibugyo strain of Ebola virus used Anthropic's Claude model to evaluate digitized health worker field reports.

The European Academies Science Advisory Council report warned that routine automation by artificial intelligence risks professional deskilling among medical staff during system outages.

Vir Biotechnology utilizes its PRO-XTEN masking technology and proprietary dAIsY AI platform to design dual-masked T-cell engager candidates against solid tumors

Professor Thomas Thesen of Dartmouth University stated that artificial intelligence chatbots create an explainability black-box problem by failing to explain pattern recognition in human-understandable language.

Merck officially opened Advance, a 120,000-square-foot research facility featuring automated robotics and AI, at its West Point, Pennsylvania campus on October 14, 2026.

Isomorphic Labs established partnerships with major pharmaceutical companies while planning to design internal therapeutic drugs using artificial intelligence.

Sound Practice 10 of the Financial Stability Board's guidance establishes a risk-based intervention model requiring mandatory human sign-off for financial transactions exceeding specific thresholds.

The Financial Stability Board published 12 non-binding recommended practices on October 16, 2026, for the responsible adoption of artificial intelligence in financial institutions across G20 economies.

Bank of England Governor Andrew Bailey proposed pre- and post-deployment testing protocols for frontier AI models used in finance and G20-level agreements governing access to foreign-built frontier models.